www.mhlw.go.jp/stf/newpage_06675.html

archives

This URL has 1 public saves. The first save was Apr 3, 2026, 12:30 PM and the latest save was Apr 3, 2026, 12:30 PM.

View recent saves on this domain

Latest saved version

www.mhlw.go.jp/stf/newpage_06675.html

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Apr 3, 2026, 12:30 PM

Source URL

https://www.mhlw.go.jp/stf/newpage_06675.html

About this page

This page documents the 17th regular opinion exchange meeting on medical device and in vitro diagnostic approval reviews held on July 29, 2019, at PMDA headquarters. The Ministry of Health, Labour and Welfare presented initiatives to accelerate access to innovative medical devices, including the Sakigake Designation System and Conditional Early Approval System. Director General Tarumi emphasized the importance of advanced technologies like genomic medicine and AI in drug development. PMDA's President Fujiwara committed to providing high-quality reviews proportional to examination fees. The meeting aimed to gather stakeholder opinions on regulatory strategies for medical devices and diagnostics.

Total saves

1

Latest save

Apr 3, 2026, 12:30 PM

First save

Apr 3, 2026, 12:30 PM

Saved versions

www.mhlw.go.jp/stf/newpage_06675.html web archives are listed here. You can still review the saved screenshot and HTML even if the original page disappears.